From a multiregion sequencing study, Zhang et al24 identified a universal spatial heterogeneity of TP53 mutation in NSCLC; therefore, the sites and timing of tumor acquisition may cause a marked difference in the positivity and frequency of TP53 mutation. The gene discussed is TP53; the disease is non-small cell lung carcinoma.